Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeMEDTRONIC plcMedtronic Expands Pain Therapies Portfolio with the Launch of OsteoCool™ RF Ablation...

Medtronic Expands Pain Therapies Portfolio with the Launch of OsteoCool™ RF Ablation System

April 27, 2017

Medtronic Canada, a subsidiary of Medtronic plc (NYSE:MDT), today announced Health Canada licensing and the launch of the OsteoCool™ RF Ablation System in Canada.

For physicians who treat patients with painful bone metastases, the OsteoCool System is currently the only cooled radiofrequency (RF) ablation technology that offers simultaneous, dual-probe capabilities — providing procedural flexibility and predictable, customized treatment. Cooled RF ablation uses high-frequency energy to target cancer cells.

In 2016, an estimated 202,400 Canadians developed cancer.1 Metastatic bone disease occurs in 60-80 percent of cancer patients, most frequently among patients with primary malignancies of the breast, prostate, liver, and lung.2 Seventy percent of metastatic bone cancer patients develop at least one lesion in the spine.3

The OsteoCool RF Ablation System offers a valid option for patients with painful bone tumors when conventional therapies are considered ineffective, too slow-acting or cause unacceptable side effects.4

“Osteocool Radiofrequency Ablation provides a minimally invasive option for the treatment of painful bone metastases and is particularly useful in patients that have not responded well to other treatment modalities,” said Dr. Roy Park in EFW Radiology in Calgary.

“Our Pain Therapies business is deeply rooted in the Medtronic Mission — which calls us to alleviate pain,” said Sandrine Moirez, senior director, Restorative Therapy Group, at Medtronic Canada. “We put an important treatment option into the hands of physicians so they can help more patients suffering from debilitating cancer pain.”

Medtronic acquired the OsteoCool technology and associated intellectual property from Baylis Medical on December 16, 2015, and partnered with the company to further innovate the system. Baylis continues to manufacture OsteoCool in Mississauga, Ontario.

The system is temperature controlled and uses internally water-cooled probes to prevent overheating of surrounding tissue during the procedure. The 17-gauge, bipolar probes are available in three lengths and may be used through a variety of cannula sizes. Because two OsteoCool RF ablation probes can be used simultaneously, the system supports a variety of ablation scenarios, accommodating unique patient and procedural needs.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy